Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis

Bibliographic reference: 

Monteiro, L., Mariano, L. C., & Warnakulasuriya, S. (2024). Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis. Oral Diseases, 30(2). https://doi.org/10.1111/ODI.14378